The World Health Organization (WHO) has just released a preliminary report on cannabidiol (CBD) with the recommendation that medical marijuana should not be a scheduled drug.
The report, published today, claims that CBD is “not associated with abuse potential”, nor does it lead to physical dependence. The report also notes that marijuana is a useful treatment for epilepsy and palliative care.
“There is increased interest from Member States in the use of cannabis for medical indications including for palliative care,” the report said.
It seems that the WHO has been compiling evidence for their assertion for some time. Responding to increased interest from said Member States, the “WHO has in recent years gathered more robust scientific evidence on therapeutic use and side effects of cannabis and cannabis components.” After months of deliberation, they concluded that medical marijuana does not carry any addiction risks.
The report also recommended imposing stronger restrictions on fentanyl which is responsible for thousands of deaths each year and is one of the biggest problem drugs in the current opioid crisis.
This isn’t news to the considerable number of cannabis advocates around the world, however, it does lend further legitimacy to the push for cannabis to be de-scheduled by the federal government.
Cannabis remains federally illegal in the United States despite mounting evidence in favor of its benefits. This latest report is just one of many that have spoken to the pros of cannabis use for medical purposes.
In conclusion, the authors of the study wrote, “recent evidence from animal and human studies shows that its use could have some therapeutic value for seizures due to epilepsy and related conditions.” They added that “current information does not justify scheduling of cannabidiol.”
The organization is set to run a fuller review of cannabis next year and intends to assess all cannabis-related substances.
Could 2018 be the year of weed?